vs
1stdibs.com, Inc.(DIBS)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
1stdibs.com, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.2倍($23.0M vs $19.6M),1stdibs.com, Inc.净利率更高(-4.5% vs -177.4%,领先172.9%),1stdibs.com, Inc.同比增速更快(0.9% vs -11.5%),1stdibs.com, Inc.自由现金流更多($3.6M vs $-23.1M),过去两年1stdibs.com, Inc.的营收复合增速更高(2.0% vs -12.2%)
1stdibs.com, Inc.是一家美国电商企业,运营线上奢侈品交易平台,主营室内设计高端家具、艺术藏品、珠宝等高端商品。品牌最初创立于巴黎,现总部设于纽约,凭借推动古董行业迈入21世纪的创新举措获得业内认可。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
DIBS vs LAB — 直观对比
营收规模更大
DIBS
是对方的1.2倍
$19.6M
营收增速更快
DIBS
高出12.3%
-11.5%
净利率更高
DIBS
高出172.9%
-177.4%
自由现金流更多
DIBS
多$26.7M
$-23.1M
两年增速更快
DIBS
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $23.0M | $19.6M |
| 净利润 | $-1.0M | $-34.7M |
| 毛利率 | 73.5% | 48.5% |
| 营业利润率 | -10.1% | -168.5% |
| 净利率 | -4.5% | -177.4% |
| 营收同比 | 0.9% | -11.5% |
| 净利润同比 | 80.0% | -28.8% |
| 每股收益(稀释后) | $-0.02 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DIBS
LAB
| Q4 25 | $23.0M | — | ||
| Q3 25 | $22.0M | $19.6M | ||
| Q2 25 | $22.1M | $21.8M | ||
| Q1 25 | $22.5M | $40.8M | ||
| Q4 24 | $22.8M | — | ||
| Q3 24 | $21.2M | $22.1M | ||
| Q2 24 | $22.2M | $22.5M | ||
| Q1 24 | $22.1M | $45.5M |
净利润
DIBS
LAB
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-3.5M | $-34.7M | ||
| Q2 25 | $-4.3M | $-33.5M | ||
| Q1 25 | $-4.8M | $-26.0M | ||
| Q4 24 | $-5.2M | — | ||
| Q3 24 | $-5.7M | $-26.9M | ||
| Q2 24 | $-4.4M | $-45.7M | ||
| Q1 24 | $-3.3M | $-32.2M |
毛利率
DIBS
LAB
| Q4 25 | 73.5% | — | ||
| Q3 25 | 74.3% | 48.5% | ||
| Q2 25 | 71.8% | 48.8% | ||
| Q1 25 | 72.4% | 48.4% | ||
| Q4 24 | 72.3% | — | ||
| Q3 24 | 71.0% | 54.9% | ||
| Q2 24 | 71.7% | 46.1% | ||
| Q1 24 | 72.5% | 53.1% |
营业利润率
DIBS
LAB
| Q4 25 | -10.1% | — | ||
| Q3 25 | -21.3% | -168.5% | ||
| Q2 25 | -25.8% | -118.1% | ||
| Q1 25 | -27.7% | -80.8% | ||
| Q4 24 | -30.6% | — | ||
| Q3 24 | -34.9% | -120.9% | ||
| Q2 24 | -29.2% | -134.5% | ||
| Q1 24 | -24.3% | -132.2% |
净利率
DIBS
LAB
| Q4 25 | -4.5% | — | ||
| Q3 25 | -16.0% | -177.4% | ||
| Q2 25 | -19.5% | -153.7% | ||
| Q1 25 | -21.3% | -63.8% | ||
| Q4 24 | -22.9% | — | ||
| Q3 24 | -26.8% | -122.0% | ||
| Q2 24 | -20.0% | -203.3% | ||
| Q1 24 | -15.0% | -70.6% |
每股收益(稀释后)
DIBS
LAB
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $-0.10 | $-0.09 | ||
| Q2 25 | $-0.12 | $-0.09 | ||
| Q1 25 | $-0.14 | $-0.07 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | $-0.07 | ||
| Q2 24 | $-0.12 | $-0.12 | ||
| Q1 24 | $-0.08 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $22.9M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $93.6M | $399.7M |
| 总资产 | $132.1M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DIBS
LAB
| Q4 25 | $22.9M | — | ||
| Q3 25 | $19.9M | $129.4M | ||
| Q2 25 | $22.4M | $158.6M | ||
| Q1 25 | $20.3M | $150.9M | ||
| Q4 24 | $26.0M | — | ||
| Q3 24 | $22.0M | $210.6M | ||
| Q2 24 | $23.8M | $269.8M | ||
| Q1 24 | $33.7M | $287.1M |
总债务
DIBS
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
DIBS
LAB
| Q4 25 | $93.6M | — | ||
| Q3 25 | $94.0M | $399.7M | ||
| Q2 25 | $94.9M | $424.5M | ||
| Q1 25 | $96.2M | $454.6M | ||
| Q4 24 | $99.3M | — | ||
| Q3 24 | $107.2M | $489.3M | ||
| Q2 24 | $110.4M | $510.3M | ||
| Q1 24 | $131.0M | $577.3M |
总资产
DIBS
LAB
| Q4 25 | $132.1M | — | ||
| Q3 25 | $135.2M | $539.6M | ||
| Q2 25 | $138.6M | $557.0M | ||
| Q1 25 | $142.5M | $579.6M | ||
| Q4 24 | $145.8M | — | ||
| Q3 24 | $154.4M | $681.5M | ||
| Q2 24 | $157.6M | $708.7M | ||
| Q1 24 | $179.5M | $777.7M |
负债/权益比
DIBS
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $3.6M | $-23.1M |
| 自由现金流率自由现金流/营收 | 15.7% | -118.1% |
| 资本支出强度资本支出/营收 | 2.9% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-3.2M | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
DIBS
LAB
| Q4 25 | $4.3M | — | ||
| Q3 25 | $-1.5M | $-22.2M | ||
| Q2 25 | $-5.1M | $-20.7M | ||
| Q1 25 | $-96.0K | $-30.3M | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $-3.0K | $-27.9M | ||
| Q2 24 | $-2.6M | $-39.0M | ||
| Q1 24 | $-3.1M | $-62.5M |
自由现金流
DIBS
LAB
| Q4 25 | $3.6M | — | ||
| Q3 25 | $-1.5M | $-23.1M | ||
| Q2 25 | $-5.2M | $-22.6M | ||
| Q1 25 | $-143.0K | $-35.3M | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $-44.0K | $-30.1M | ||
| Q2 24 | $-3.0M | $-41.0M | ||
| Q1 24 | $-3.3M | $-63.3M |
自由现金流率
DIBS
LAB
| Q4 25 | 15.7% | — | ||
| Q3 25 | -6.8% | -118.1% | ||
| Q2 25 | -23.4% | -103.6% | ||
| Q1 25 | -0.6% | -86.6% | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | -0.2% | -136.4% | ||
| Q2 24 | -13.5% | -182.2% | ||
| Q1 24 | -14.8% | -138.9% |
资本支出强度
DIBS
LAB
| Q4 25 | 2.9% | — | ||
| Q3 25 | 0.1% | 4.5% | ||
| Q2 25 | 0.2% | 8.7% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 0.2% | 10.2% | ||
| Q2 24 | 1.6% | 8.6% | ||
| Q1 24 | 0.9% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DIBS
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |